Skip to content. Skip to navigation
Sections
Personal tools
You are here: Home Events The 6th Annual Pain Therapeutics Summit
Navigation
Log in


Forgot your password?
New user?
Site Search
 
Search only the current folder (and sub-folders)
 
Document Actions

The 6th Annual Pain Therapeutics Summit

Type Conference
Date October 3, 2012 to
October 4, 2012
Venue TBA

San Francisco, CA
US
Chemistry Specialties
  • other
Chemistry Techniques
  • other
Contact John Waslif
Arrowhead Publishers and Conferences
5412 Irving Ave South
Minneapolis, MN 55419
US
312-244-3703
312-244-3703
john.waslif@arrowheadpublishers.com
Add event to calendar vCal (Windows, Linux)
iCal (Mac OS X)
by John Waslif last modified 06-15-12 07:25 AM

ARROWHEAD’S ANNUAL PAIN THERAPEUTICS SUMMIT is the US’s premier conference covering the field of pain management and therapeutics. Leaders from the pharmaceutical, biotech, device and medical communities attend this conference to learn about the latest advances in the treatment of various types of pain and to network with colleagues from industry, the non-profit sector, academia, the medical community, government and investors. This conference will provide attendees with thoughtful insight from key industry leaders and academic researchers concerning cutting edge drug discovery science, preclinical development trends, analysis of key clinical-stage pain therapies and newly marketed products. We will highlight the most important developments in recent years in the field, including new research in CGRP antagonists, NGF antagonists, Nav 1.7 antagonists, new research in biologic therapies and the genetic component of pain, abuse-resistant opioids, analysis of FDA’s REMS program and a plethora of other topics.

ARROWHEAD’S ANNUAL PAIN THERAPEUTICS SUMMIT is the US’s premier conference covering the field of pain management and therapeutics. Leaders from the pharmaceutical, biotech, device and medical communities attend this conference to learn about the latest advances in the treatment of various types of pain and to network with colleagues from industry, the non-profit sector, academia, the medical community, government and investors. This conference will provide attendees with thoughtful insight from key industry leaders and academic researchers concerning cutting edge drug discovery science, preclinical development trends, analysis of key clinical-stage pain therapies and newly marketed products. We will highlight the most important developments in recent years in the field, including new research in CGRP antagonists, NGF antagonists, Nav 1.7 antagonists, new research in biologic therapies and the genetic component of pain, abuse-resistant opioids, analysis of FDA’s REMS program and a plethora of other topics.

More information about this event…

« May 2013 »
Su Mo Tu We Th Fr Sa
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31
Sponsors
Web Search
 

Powered by Plone CMS, the Open Source Content Management System

This site conforms to the following standards: